Journal

Platelet-rich plasma: benefits and drawbacks

Platelet-rich plasma: benefits by area, real drawbacks, and who is not a candidate. Evidence, limits, and clinical reasoning explained with clarity.

Longevia MedicalOctober 31, 2026Leer en español

Platelet-rich plasma: benefits and drawbacks before deciding

Platelet-rich plasma raises many questions and, often, expectations that exceed what the evidence supports. Before considering whether it applies to you, it is worth understanding what the medical literature says about its benefits, what remains under discussion, and what its real drawbacks are: variable response, the need for multiple sessions, and evidence that is not consistent across all areas of the body.

At Longevia Medical, in Puerto Cancún, platelet-rich plasma is proposed only when the clinical assessment identifies an indication that supports it. If there is none, it is not proposed. What follows is an explanation of the procedure as medicine describes it today.

What platelet-rich plasma is and how it works

Platelet-rich plasma, known as PRP, is a fraction of the patient's own blood with a high concentration of platelets. It is obtained by drawing a small blood sample, processing it in a centrifuge, and reinjecting the concentrated fraction into the target tissue. Because it is autologous, derived from the patient's own body, the risk of rejection is minimal.

Platelets release growth factors that participate in the body's natural tissue repair processes. The working hypothesis is that concentrating those factors in a specific area can accelerate or support those processes. That is what the evidence explores, with varying results depending on the area and the indication.

PRP introduces no external substance into the body. What it does is concentrate what the blood already contains and direct it toward an area where there is a clinical indication for its use.

Platelet-rich plasma: benefits described by area

The benefits of platelet-rich plasma are not uniform. The evidence varies considerably depending on the tissue to which it is applied. There are areas where clinical support is more consistent, areas where it remains under investigation, and areas where it is not indicated or where published results are unclear.

Tendons and joints

Application to tendons and joints with wear or chronic injury is one of the most studied areas. In tendinopathies, such as those of the patellar tendon or the rotator cuff, several studies describe improvement in pain and function. In knee osteoarthritis, published reports note pain relief, although the response is not the same across all disease grades or all patients.

What the evidence does not support is complete structural regeneration of cartilage. PRP can support the biological environment of the tissue, but it does not rebuild what has already been irreversibly lost.

Scalp and hair loss

In androgenic alopecia, applying platelet-rich plasma to the scalp has support from studies describing increases in hair density and thickness. The effect requires a series of sessions and, in most published protocols, follow-up maintenance sessions. Without maintenance, the loss process typically resumes.

In cicatricial or autoimmune alopecias, the indication is different and the evidence is more limited. The cause of hair loss must be established before deciding whether PRP is appropriate.

Skin: quality, texture, and healing

In medical aesthetics, PRP is used to improve skin quality, reduce acne scarring, and support recovery after other procedures. The evidence in acne scars is reasonable; in general skin aging, studies describe improvement in hydration and elasticity, though results vary according to technique, preparation concentration, and individual response.

It is not a substitute for procedures with stronger evidence for volume loss or significant laxity. Its most solid role in skin is as a complement within a broader protocol, not as a standalone intervention for every objective.

Healing and post-surgical recovery

There are areas of orthopedic and reconstructive surgery where PRP is used as an adjunct to support healing. The evidence in this context is variable: some studies show benefit in recovery speed, others find no significant difference. The indication is defined by the attending surgeon, not the patient.

Platelet-rich plasma: real drawbacks and limits

The drawbacks of platelet-rich plasma are concrete and worth understanding before deciding. Biological response is not the same in every person. Age, general health, individual platelet concentration, and preparation technique all influence the outcome. No one can promise you a specific result.

Variable response

Two people with the same indication and the same protocol can have different responses. This is not a flaw in the procedure: it is the nature of biological therapies. Individual response depends on factors that cannot always be fully controlled or predicted ahead of the first session.

Multiple sessions required

A single session is rarely sufficient. Published protocols for most indications describe a series of sessions with defined intervals. This means time, follow-up, and, in some indications such as alopecia, long-term maintenance sessions. If a person cannot commit to the full series, the outcome is less predictable.

Evidence differs by area

Not all PRP applications carry the same level of clinical support. Some indications are well studied, some are under active investigation, and some have published data that are still insufficient for a firm recommendation. Presenting PRP as a universal treatment with uniform evidence across all areas would be inaccurate.

The least intervention that addresses the objective responsibly is always the starting point. PRP is no exception.

Procedural risks

Because it is autologous, PRP has a favorable safety profile. The most common side effects are local and transient: pain at the application site, inflammation, and bruising. Infections, vascular reactions, and more serious complications are infrequent, but they do occur when technique is not rigorous. If after a session you experience sudden changes in vision, skin that turns white or violet, intense pain, difficulty breathing, chest pain, or any new neurological symptom, you need emergency care immediately, not a message to the clinic.

flowchart TD
    A["Initial consultation: reason and area"] --> B["Clinical assessment: indication confirmed"]
    B --> C{"Is there evidence for this indication?"}
    C -->|"Yes, supported"| D["Protocol: series of sessions with follow-up"]
    C -->|"Under investigation"| E["Evidence status is communicated and decision is made with the patient"]
    C -->|"Not applicable"| F["Other options with stronger indication are explored"]
    D --> G["Individual response assessment"]
    E --> G
    G --> H["Follow-up: continues after the patient returns home"]

Who is not a candidate for platelet-rich plasma

Candidacy for PRP has clear contraindications. There are conditions in which the procedure should not be performed and others that require careful assessment before a decision is made. Understanding them is part of making an informed choice.

  • Coagulation disorders: people taking anticoagulants or with conditions that affect platelet function are not straightforward candidates. The indication must be evaluated with a complete medical history.
  • Thrombocytopenia: a low platelet count means the preparation will not have the concentration needed to serve its purpose. Without sufficient platelets, the procedure has no clinical basis.
  • Active infection at the application site: introducing any preparation into infected tissue is contraindicated.
  • Active cancer or recent history of hematologic malignancies: the growth factors released by PRP must not be applied in active oncological contexts. This is a contraindication without exceptions.
  • Pregnancy: the safety evidence in pregnancy is insufficient to support elective use.
  • Expectations that the indication cannot fulfill: if hair loss is cicatricial rather than androgenic, if joint damage is end-stage, or if skin laxity is severe, PRP is not the tool with the strongest support for those objectives. Proposing the procedure without that clarity is not responsible medicine.

There are also situations that are not absolute contraindications but do require more detailed assessment: use of certain anti-inflammatory medications, uncontrolled diabetes, active tobacco use, and some autoimmune conditions. In all these cases, the decision is made during the clinical assessment, with a complete medical history in hand.

How we determine whether PRP applies to you

The prior clinical assessment is not a formality: it is the only moment at which we can decide with sound judgment whether platelet-rich plasma has an indication in your case, which area, which protocol, and how many sessions would be appropriate to propose. Without that information, any answer is speculation.

At Longevia Medical, care begins with an assessment, in person in Puerto Cancún or remote. The plan is individual and delivered in writing. Follow-up continues after the patient returns home. If the assessment confirms the indication, we explain what to expect, within what general timeframe, and how response is measured. If it does not confirm the indication, we explore other options with clinical support better suited to that objective.

For those who want to study the subject more thoroughly before making a decision, the articles on what stem cells are used for: evidence and limits and on how to evaluate a stem cell therapy clinic in Mexico offer a useful framework for understanding how to read evidence in regenerative medicine before choosing where to seek care.

A well-conducted assessment cannot promise an outcome, but it does eliminate the indications where the procedure makes no sense. That alone is substantial.

Frequently asked questions about platelet-rich plasma

How long do the effects of platelet-rich plasma last?

How long the effect lasts depends on the area treated, the indication, and the individual response. In alopecia, maintenance protocols are standard because without them the loss process resumes. In tendons and joints, the duration of benefit varies with the severity of the injury and the patient's lifestyle. No one can promise you a fixed duration.

How many platelet-rich plasma sessions are needed?

The number of sessions depends on the indication and the protocol the evidence supports for that area. Most published protocols describe an initial series of sessions, not a single one. After the initial series, some indications require maintenance sessions. This is determined during the clinical assessment, not before.

Does platelet-rich plasma hurt?

The sensation during and after a session varies according to the application area and each person's threshold. Local discomfort, mild inflammation, and sensitivity at the injection site in the days that follow are common. In most cases these are transient. If the pain is intense, if the skin changes color, or if systemic symptoms appear, you need emergency medical attention immediately.

How does platelet-rich plasma differ from stem cells?

PRP is a concentrated fraction of the patient's own blood, rich in platelets and growth factors. Stem cell therapies work with cells that have differentiation capacity. They are distinct mechanisms with distinct indications and distinct levels of evidence depending on the condition. They are not interchangeable, nor is one categorically superior to the other.

Who cannot receive platelet-rich plasma?

Contraindications include coagulation disorders, thrombocytopenia, active infection at the application site, active cancer or recent history of hematologic malignancies, and pregnancy. Some conditions are not absolute contraindications but do require detailed assessment. Candidacy is confirmed only with a complete clinical history.

For broader information on these therapies from a patient perspective, Mayo Clinic and MedlinePlus offer general reference materials in both Spanish and English.

Begin privately

Tell us what you want to protect.

This first conversation is for orientation, not diagnosis. A coordinator will identify the right clinical pathway and explain the secure next step.

Request a private consultation↗

Book a private consultation

Tell us what you want to protect.

Choose a preferred date and time. A coordinator confirms your appointment by WhatsApp or email and explains the secure next step. This first conversation is for orientation, not diagnosis.

Do not include medical records or sensitive health information here.
Thank you. We received your request. A coordinator will confirm your appointment by WhatsApp or email.